Globus Medical Acquires Nevro for $250 Million

Globus Medical (GMED) entered a merger agreement on February 6, 2025, to acquire Nevro Corp. (NVRO) in an all-cash deal valued at $250 million.

Deal Structure:

As per the terms of the agreement, Globus Medical will acquire all shares of Nevro for $5.85 per share, representing a 16.53% premium from the stock’s last close.

Please subscribe for free or login to your InsideArbitrage account to access this article.